Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1995 Sep 25;23(18):3726–3731. doi: 10.1093/nar/23.18.3726

5'-Cholesteryl-phosphorothioate oligodeoxynucleotides: potent inhibition of methotrexate transport and antagonism of methotrexate toxicity in cells containing the reduced-folate carrier.

G B Henderson 1, C A Stein 1
PMCID: PMC307272  PMID: 7479003

Abstract

Polyanionic 5'-cholesteryl-phosphorothioate oligodeoxynucleotides of varying polymer length and nucleobase composition were examined for an effect on methotrexate transport via the reduced-folate carrier of L1210 mouse cells. Methotrexate transport was inhibited by each of the oligodeoxynucleotide analogs tested. Inhibition was most pronounced (IC50 = 0.21 microM, standard assay) for a 5'-cholesteryl heteropolymer consisting of 15 phosphorothioate deoxynucleotides with alternating deoxycytosine and deoxyadenosine (Chol-PS-d(CA)7C). Homopolymers with 15 deoxycytosine (Chol-PS-dC15) or deoxythymidine (Chol-PS-dT15) residues were approximately 2-fold less inhibitory than Chol-PS-d(CA)7C. The relative potency of transport inhibition by deoxycytosine oligomers of varying length was: Chol-PS-dC5 > Chol-PS-dC15 > Chol-PS-dC28 > Chol-PS-dC3. Substantial inhibition was retained in cells preincubated with inhibitors and washed prior to transport determinations and the inhibitor sensitivity could be increased substantially by reducing the concentration of cells. Mixed competitive and non-competitive inhibition was observed for each analog. In standard high-folate medium, Chol-PS-oligodeoxynucleotides (5.0 microM) had minimal effects on the growth of L1210 cells, but antagonized the cytotoxicity of methotrexate. The response to methotrexate (IC50 = 12 nM) decreased to the greatest extent (20.8-fold) in the presence of Chol-PS-d(CA)7C (IC50 = 250 nM). Under limiting folate conditions, Chol-PS-d(CA)7C alone inhibited cells growth by a process which could be reversed by folic acid. The results show that Chol-PS-oligodeoxynucleotides are among the most potent known inhibitors of the reduced-folate carrier. Direct growth inhibition of folate-deficient cells and antagonism of methotrexate cytotoxicity indicate that Chol-PS-oligodeoxynucleotides retain the ability to inhibit the reduced-folate carrier for several days in cultured cells.

Full text

PDF
3726

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Henderson G. B. Folate-binding proteins. Annu Rev Nutr. 1990;10:319–335. doi: 10.1146/annurev.nu.10.070190.001535. [DOI] [PubMed] [Google Scholar]
  2. Henderson G. B., Montague-Wilkie B. Irreversible inhibitors of methotrexate transport in L1210 cells. Characteristics of inhibition by an N-hydroxysuccinimide ester of methotrexate. Biochim Biophys Acta. 1983 Oct 26;735(1):123–130. doi: 10.1016/0005-2736(83)90267-5. [DOI] [PubMed] [Google Scholar]
  3. Henderson G. B., Russell A., Whiteley J. M. A fluorescent derivative of methotrexate as an intracellular marker for dihydrofolate reductase in L1210 cells. Arch Biochem Biophys. 1980 Jun;202(1):29–34. doi: 10.1016/0003-9861(80)90402-6. [DOI] [PubMed] [Google Scholar]
  4. Henderson G. B., Russell A., Whiteley J. M. A fluorescent derivative of methotrexate as an intracellular marker for dihydrofolate reductase in L1210 cells. Arch Biochem Biophys. 1980 Jun;202(1):29–34. doi: 10.1016/0003-9861(80)90402-6. [DOI] [PubMed] [Google Scholar]
  5. Henderson G. B., Strauss B. P. Characteristics of a novel transport system for folate compounds in wild-type and methotrexate-resistant L1210 cells. Cancer Res. 1990 Mar 15;50(6):1709–1714. [PubMed] [Google Scholar]
  6. Henderson G. B., Zevely E. M. Characterization of the multiple transport routes for methotrexate in L1210 cells using phthalate as a model anion substrate. J Membr Biol. 1985;85(3):263–268. doi: 10.1007/BF01871521. [DOI] [PubMed] [Google Scholar]
  7. Henderson G. B., Zevely E. M. Intracellular phosphate and its possible role as an exchange anion for active transport of methotrexate in L1210 cells. Biochem Biophys Res Commun. 1982 Jan 29;104(2):474–482. doi: 10.1016/0006-291x(82)90661-1. [DOI] [PubMed] [Google Scholar]
  8. Henderson G. B., Zevely E. M. Transport routes utilized by L1210 cells for the influx and efflux of methotrexate. J Biol Chem. 1984 Feb 10;259(3):1526–1531. [PubMed] [Google Scholar]
  9. Henderson G. B., Zevely E. M. Use of non-physiological buffer systems in the analysis of methotrexate transport in L1210 cells. Biochem Int. 1983 Apr;6(4):507–515. [PubMed] [Google Scholar]
  10. Higgins K. A., Perez J. R., Coleman T. A., Dorshkind K., McComas W. A., Sarmiento U. M., Rosen C. A., Narayanan R. Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9901–9905. doi: 10.1073/pnas.90.21.9901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Krieg A. M., Tonkinson J., Matson S., Zhao Q., Saxon M., Zhang L. M., Bhanja U., Yakubov L., Stein C. A. Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy. Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1048–1052. doi: 10.1073/pnas.90.3.1048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Letsinger R. L., Zhang G. R., Sun D. K., Ikeuchi T., Sarin P. S. Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6553–6556. doi: 10.1073/pnas.86.17.6553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Loke S. L., Stein C. A., Zhang X. H., Mori K., Nakanishi M., Subasinghe C., Cohen J. S., Neckers L. M. Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci U S A. 1989 May;86(10):3474–3478. doi: 10.1073/pnas.86.10.3474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  15. Rideout D. C., Bustamante A., Patel R., Henderson G. B. Suramin sodium: pronounced effects on methotrexate transport and anti-folate activity in cultured tumor cells. Int J Cancer. 1995 Jun 9;61(6):840–847. doi: 10.1002/ijc.2910610616. [DOI] [PubMed] [Google Scholar]
  16. Saxon M., Schieren I., Zhang L. M., Tonkinson J. L., Stein C. A. Stimulation of calcium influx in HL60 cells by cholesteryl-modified homopolymer oligodeoxynucleotides. Antisense Res Dev. 1992 Fall;2(3):243–250. doi: 10.1089/ard.1992.2.243. [DOI] [PubMed] [Google Scholar]
  17. Stein C. A., Cheng Y. C. Antisense oligonucleotides as therapeutic agents--is the bullet really magical? Science. 1993 Aug 20;261(5124):1004–1012. doi: 10.1126/science.8351515. [DOI] [PubMed] [Google Scholar]
  18. Stein C. A., Pal R., DeVico A. L., Hoke G., Mumbauer S., Kinstler O., Sarngadharan M. G., Letsinger R. L. Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro. Biochemistry. 1991 Mar 5;30(9):2439–2444. doi: 10.1021/bi00223a020. [DOI] [PubMed] [Google Scholar]
  19. Stein C. A., Subasinghe C., Shinozuka K., Cohen J. S. Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res. 1988 Apr 25;16(8):3209–3221. doi: 10.1093/nar/16.8.3209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Stein C. A., Tonkinson J. L., Zhang L. M., Yakubov L., Gervasoni J., Taub R., Rotenberg S. A. Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells. Biochemistry. 1993 May 11;32(18):4855–4861. doi: 10.1021/bi00069a022. [DOI] [PubMed] [Google Scholar]
  21. Tonkinson J. L., Stein C. A. Patterns of intracellular compartmentalization, trafficking and acidification of 5'-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells. Nucleic Acids Res. 1994 Oct 11;22(20):4268–4275. doi: 10.1093/nar/22.20.4268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. de Smidt P. C., Le Doan T., de Falco S., van Berkel T. J. Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution. Nucleic Acids Res. 1991 Sep 11;19(17):4695–4700. doi: 10.1093/nar/19.17.4695. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES